Recent 8-K filings for CRAC

• August 26, 2026, 4:37 PM ET M&A materiality 0.50 neutral item 1.01item 9.01

  Crown Reserve and Carvix amend business combination agreement to clarify voting thresholds and executive salaries

  On Aug 26, 2026, Crown Reserve, Merger Sub, and Carvix amended the March 30, 2026 Business Combination Agreement.

• April 3, 2026, 7:59 PM ET M&A materiality 0.85 neutral item 1.01item 9.01 ◈ Material Agreements

  Crown Reserve (CRAC) enters definitive business combination with Carvix

  SPAC merges with Carvix via domestication to Delaware; Carvix management team continues leading combined company.

• April 2, 2026, 7:59 PM ET M&A materiality 0.90 positive item 7.01item 9.01

  Crown Reserve SPAC announces $1.0B business combination with Carvix

  Transaction values Carvix at $1.0B implied enterprise value; all-stock at $10.00/share reference price.

• December 4, 2025, 6:59 PM ET other material materiality 0.20 neutral item 8.01item 9.01

  Crown Reserve Acquisition announces separate trading of shares, warrants, rights from Dec 9, 2025

  Holders of CRACU units may elect to separate into Class A shares (CRAC), warrants (CRACW), and rights (CRACR) starting Dec 9, 2025.

• November 12, 2025, 6:59 PM ET other material materiality 0.50 neutral item 1.01item 3.02item 5.02item 5.03item 8.01item 9.01 ◈ Equity Issuances◈ Governance Changes

  Crown Reserve Acquisition Corp. I closes $172.5M SPAC IPO on Nasdaq

  Priced 17.25M units at $10/unit; gross proceeds $172.5M including full exercise of over-allotment.

Materiality & sentiment trend

Max materiality 0.90 · Median 0.50 · Most common event m_and_a

1 positive 0 negative 4 neutral

source · CRAC on sec.gov